With doses of 10 nmol/kg and higher, rats exhibited not only a lack of activity, but also notable changes in facial expressions associated with pain and nausea including orbital tightening and nose/cheek flattening compared to rats treated with vehicle alone
Protocol 2: CJC-1295 With DAC Plus Ipamorelin CJC-1295 with DAC: 1,000-2,000 mcg subcutaneous injection once weekly Ipamorelin: 200-300 mcg subcutaneous injection, 2x daily Cycle length: 12-16 weeks Monitoring: Fasting IGF-1 at baseline and at 8 weeks
Taking acetyl-L-carnitine by mouth along with propionyl-L-carnitine seems to help symptoms related to declining male hormone levels
The drug binds DNA, which is toxic to dividing tumor cells
Personal or family history of medullary thyroid cancer (MTC) : Due to the potential increased risk of MTC linked to Semaglutide GLP-1, people with a personal or family history of MTC should not use this medication
BPC-157 currently lacks approval for therapeutic use in humans